An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine pancreatic cancer
Article in Biochemical and Biophysical Research Communications (April 2024)
The most recent citing publications are shown below. View all 56 publications that cite this research output on Dimensions.
Article in Biochemical and Biophysical Research Communications (April 2024)
Article in Frontiers of Medicine (March 2024)
Article in Journal of Hepatocellular Carcinoma (January 2024)